Paul L. Ornstein

6.7k citations

96 papers · 5.1k indexed · h-index 42

Cellular and Molecular Neuroscience top 0.2%
Molecular Biology top 2%
Organic Chemistry top 2%
Cognitive Neuroscience top 2%
Physiology top 5%

Co-authors: David Lodge Darryle D. Schoepp David Bleakman M. Brian Arnold Graham L. Collingridge Rebecca A. Wright J. David Leander Zuner A. Bortolotto
Topics: Neuroscience and Neuropharmacology Research (54 papers)Receptor Mechanisms and Signaling (24 papers)Ion channel regulation and function (15 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Cognitive Neuroscience
Journals: Nature Journal of Biological Chemistry Neuron
Partner nations: United States United Kingdom Spain

In The Last Decade

Paul L. Ornstein

95 papers receiving 4.9k citations

Peers

Countries citing papers authored by Paul L. Ornstein

Since Specialization

Citations

This map shows the geographic impact of Paul L. Ornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Ornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Ornstein more than expected).

Fields of papers citing papers by Paul L. Ornstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Ornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Ornstein. The network helps show where Paul L. Ornstein may publish in the future.

Co-authorship network of co-authors of Paul L. Ornstein

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Ornstein. A scholar is included among the top collaborators of Paul L. Ornstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Ornstein. Paul L. Ornstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anxiolytic-like effects through a GLUK5 kainate receptor mechanism 2007 ·Neuropharmacology ·Andrew Alt,(unknown),Paul L. Ornstein,Scott D. Gleason,David Bleakman,Robert E. Stratford,Jeffrey M. Witkin	19
2	Privileged structure based ligands for melanocortin-4 receptors—Aliphatic piperazine derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Karin Briner,Iván Collado,Matthew J. Fisher,(unknown),(unknown),(unknown),(unknown),Thomas P. O’Brien,Paul L. Ornstein,John M. Zgombick,Óscar de Frutos	12
3	Privileged structure-based ligands for melanocortin receptors—tetrahydroquinolines, indoles, and aminotetralines 2005 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Fisher,(unknown),(unknown),Hansen M. Hsiung,Jeffrey T. Mullaney,(unknown),Paul L. Ornstein,(unknown),John M. Zgombick,Karin Briner	22
4	A Role for Ca2+ Stores in Kainate Receptor-Dependent Synaptic Facilitation and LTP at Mossy Fiber Synapses in the Hippocampus 2003 ·Neuron ·Sari E. Lauri,Zuner A. Bortolotto,Robert Nisticò,David Bleakman,Paul L. Ornstein,David Lodge,John Isaac,Graham L. Collingridge	159
5	A Critical Role of a Facilitatory Presynaptic Kainate Receptor in Mossy Fiber LTP 2001 ·Neuron ·Sari E. Lauri,Zuner A. Bortolotto,David Bleakman,Paul L. Ornstein,David Lodge,John Isaac,Graham L. Collingridge	162
6	LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia 2000 ·Neuropharmacology ·Michael J. O’Neill,(unknown),Caroline Hicks,Ann Bond,Mark Ward,Guy Ebinger,Paul L. Ornstein,Yvette Michotte,David Lodge	51
7	A novel, competitive mGlu₅ receptor antagonist (LY344545) blocks DHPG‐induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices 2000 ·British Journal of Pharmacology ·Andrew J. Doherty,Mary J. Palmer,Z A Bortolotto,(unknown),Ann E. Kingston,Paul L. Ornstein,D D Schoepp,David Lodge,G.L. Collingridge	67
8	Kainate receptors are involved in synaptic plasticity 1999 ·Nature ·Zuner A. Bortolotto,Vernon R. J. Clarke,(unknown),Michael C. Parry,Ilse Smolders,Michel Vignes,Ken H. Ho,Peter Miu,Bradford T. Brinton,(unknown),Ann Marie L. Ogden,Mary Gates,Paul L. Ornstein,David Lodge,David Bleakman,Graham L. Collingridge	265
9	Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord 1998 ·Neuropharmacology ·(unknown),Andrea K. Houghton,E. S. Louise Faber,Boris A. Chizh,Paul L. Ornstein,D Lodge,P.M. Headley	48
10	Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat 1998 ·Neuropharmacology ·Rosa Maria A. Simmons,Dominic L. Li,Ken H. Hoo,(unknown),Paul L. Ornstein,Smriti Iyengar	137
11	Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists 1998 ·Bioorganic & Medicinal Chemistry Letters ·Paul L. Ornstein,M. Brian Arnold,W. H. W. LUNN,(unknown),J. David Leander,David Lodge,(unknown)	16
12	The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus 1998 ·Neuropharmacology ·Michel Vignes,Vernon R. J. Clarke,Mair Parry,David Bleakman,David Lodge,Paul L. Ornstein,Graham L. Collingridge	126
13	Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid. 1996 ·Molecular Pharmacology ·(unknown),Darryle D. Schoepp,Barbara A. Ballyk,(unknown),(unknown),Kenneth A. Thomas,Paul L. Ornstein,R. K. Kamboj	91
14	6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists 1992 ·Journal of Medicinal Chemistry ·Paul L. Ornstein,Darryle D. Schoepp,M. Brian Arnold,(unknown),David Lodge,John D. Millar,John Chambers,(unknown),Jonathan W. Paschal	25
15	Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones 1992 ·Journal of Medicinal Chemistry ·Loretta A. McQuaid,Edward C. Smith,(unknown),Charles H. Mitch,Darryle D. Schoepp,(unknown),David O. Calligaro,Patrick J. O’Malley,D Lodge,Paul L. Ornstein	50
16	NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal 1991 ·European Journal of Pharmacology ·Kurt Rasmussen,Ray W. Fuller,Marsha E. Stockton,(unknown),(unknown),Paul L. Ornstein	125
17	Neuroprotectant effects of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist 1991 ·Journal of Neural Transmission ·Darryle D. Schoepp,Paul L. Ornstein,Craig R. Salhoff,J. David Leander	37
18	4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action 1991 ·Journal of Medicinal Chemistry ·Paul L. Ornstein,D D Schoepp,M. Brian Arnold,J. David Leander,David Lodge,Jonathan W. Paschal,T. K. ELZEY	76
19	CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo 1989 ·Journal of Neural Transmission ·Darryle D. Schoepp,Craig R. Salhoff,(unknown),Paul L. Ornstein	18
20	N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugs 1988 ·Brain Research ·J. David Leander,(unknown),Paul L. Ornstein,Dennis M. Zimmerman	91

About Paul L. Ornstein

Paul L. Ornstein is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Molecular Biology, having authored 96 papers that have together received 5.1k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (54 papers), Receptor Mechanisms and Signaling (24 papers) and Ion channel regulation and function (15 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.6k citations), Biological Psychiatry (124 citations) and Cognitive Neuroscience (865 citations). Paul L. Ornstein has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include David Lodge, Darryle D. Schoepp, David Bleakman, M. Brian Arnold, Graham L. Collingridge, Rebecca A. Wright, J. David Leander, Zuner A. Bortolotto, Vernon R. J. Clarke and Michael E. Jung. Their work appears in journals such as Nature, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact